Financial Summary


Akorn Inc.

Akorn Inc. (AKRX)

0.09 €
-0.0937 (-51.01%)
Neutral
B+
Market Info
Financial Info
Financial Modelling
Symbol AKRX
Price 0.09$
Beta 1.86
Volume Avrg. 7.62M
Market Cap 0.01B
Shares (2019) 125,977.00K
Last Div 0
Dividend Yield -
DCF Unlevered 420.38 Strong Buy
DCF Levered 1,490.30 Strong Buy
ROE -96.79% Strong Sell
ROA -17.60% Sell
Operating Margin -27.56% Sell
Debt / Equity 450.01% Strong Buy
P/E -0.83
P/B 0.81 Buy

Income Statement

Quarter data

Balance Sheet Statement

Quarter data
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Short-term debt ---5.500.5010.4552.91-3.90-843.33
Other Assets 6.601.6544.3980.6882.11143.79685.876.3611.157.7329.34
Total current liabilities 21.6721.9428.2943.2961.24134.16231.51175.56171.09170.82985.59
Cash and cash equivalents 1.6241.6283.9640.7834.1870.68346.27200.77368.12224.87144.80
Long-term debt 3.723.47100.81104.64108.751,114.481,021.49809.98815.20820.41843.33
Cash and short-term investments 1.6241.6283.9640.7834.1877.95352.21201.88368.12224.89144.80
Total debt 5.853.47100.81110.14109.251,124.931,074.40809.98819.10820.41843.33
Inventories 13.1718.9235.4652.4955.98131.31185.32174.79183.57173.65170.05
Deferred revenue -----------
Goodwill and Intangible Assets 4.623.1279.6995.81145.73982.99938.341,043.15854.79568.86483.72
Total non-current liabilities 3.723.47120.65125.19110.381,385.981,259.63978.98907.18880.5768.76
Total non-current assets 36.0935.85106.81130.18180.841,268.781,361.551,287.911,179.36911.44808.59
Total liabilities 8.462.42148.94168.48171.631,520.151,491.141,154.541,078.271,051.391,054.35
Total assets 68.76111.12307.14369.56431.811,906.902,112.711,973.721,909.511,495.261,288.64
Other comprehensive income --17.9517.9517.95------
Short-term investments --10.1410.3010.017.275.941.11-0.02-
Property, Plant & Equipment Net 31.4732.7344.3980.6882.11143.79179.61238.40313.42334.85295.53
Net Debt 4.24-38.1516.8569.3675.071,054.25728.14609.21450.98595.54698.52
Investments --10.1410.3010.017.486.071.11-0.02-
Total shareholders equity 38.6486.75158.21201.08260.18386.75621.57819.18831.25443.87234.29
Retained earnings (deficit) ---72.37-37.0015.3750.71180.05319.29294.74-107.17-333.90
Long-term investments --10.1410.3010.010.210.130.01---
Receivables 9.2211.2725.3151.0265.00220.72150.62283.15141.38153.13134.17
Payables 3.294.8917.8721.7823.0044.1246.0259.5351.9839.5744.96
Total current assets 26.0773.61155.95158.71168.86494.33751.16685.81730.15583.82480.05

Cash Flow Statement

Quarter data
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Operating Cash Flow -1.0412.2823.0026.2457.3330.92297.65167.76249.26-68.89-36.92
Free Cash Flow -2.197.578.155.7945.68-7.18265.8888.87153.89-138.06-67.45
Capital Expenditure 1.154.7114.8520.4511.6438.1031.7778.8995.3769.1630.53
Depreciation & Amortization 5.455.037.1911.6013.4191.5496.0398.7290.3988.02101.85
Acquisitions and disposals ------987.80-929.77----
Deferred income taxes ---4.410.072.0925.29-46.13-32.93-115.25-37.40-0.34
Investment purchases --------45.00---
Accounts payables -5.511.615.894.491.9811.02-4.826.14-9.22-5.005.49
Sales/Maturities of investments -----------
Change in working capital -18.2447.2775.99-12.24-7.80252.55159.48-9.3948.81-146.07-918.54
Debt repayment --6.44-5.10--3.03-85.05-10.45-200.00--0.01-0.35
Other non-cash items -----------
Investing Cash Flow -1.4031.55-98.38-75.50-66.87-966.54-53.72-72.92-90.56-69.13-30.40
Cash at beginning of period 1.061.6241.6283.9640.7834.1870.68346.27200.77369.89225.79
Stock-based compensation 2.362.745.167.037.057.5413.0015.4121.0221.5021.28
Net cash flow / Change in cash 0.5540.0142.34-43.18-6.6036.50275.59-145.49167.35-144.09-80.19
Effect of forex changes on cash ----0.29-0.17-0.18-0.250.001.04-1.030.06
Financing Cash Flow 2.99-3.83117.726.373.12972.3131.91-240.337.59-5.04-12.93
Dividend payments -----------
Accounts receivables -2.70-2.04-13.58-23.86-14.28-95.4740.29-132.62141.98-11.6318.88
Cash at end of period 1.6241.6283.9640.7834.1870.68346.27200.77368.12225.79145.61
Net cash provided by operating activities -1.0412.2823.0026.2457.3330.92297.65167.76249.26-68.89-36.92
Other working capital 4.4051.67127.66115.42107.61360.16519.64510.26559.06413.00-505.54
Inventory 17.00-5.75-9.31-15.45-3.80-15.26-50.7310.21-8.379.693.88

Retained Earning Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Retained Earnings (Previous Year) ----72-371551180319295-107
Net Income -252243355235151184-25-402-227
Stock Dividends 25-22-115----21-45--0
Dividend Paid -----------
Retained Earnings ---72-371551180319295-107-334

PPE Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Gross PPE 343133448182144180238313335
Annual Depreciation -4-3-316-10244-20-20-48-70
Capital Expenditure 15152012383279956931
Net PPE 3133448182144180238313335296

Intangible and Goodwill Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Intangible and Goodwill (Previous Year) 65380961469839381,043855569
New Purchases --------45---
Intangible and Goodwill 5380961469839381,043855569484

About


None
Healthcare
Drug Manufacturers
Nasdaq Global Select

Akorn Inc is a United States based generic pharmaceutical company. It develops, manufactures and markets generic and branded prescription pharmaceuticals as well as private-label over-the-counter consumer health products and animal health pharmaceuticals.